192 related articles for article (PubMed ID: 22943117)
1. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.
Schmitt-Hoffmann AH; Roos B; Schoetzau A; Leese PT; Meyer I; van de Wetering J; Kovacs P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):373-88. PubMed ID: 22943117
[TBL] [Abstract][Full Text] [Related]
2. The single-dose pharmacokinetics of alitretinoin and its metabolites are not significantly altered in patients with cirrhosis.
Thyssen JP; Vester L; Grønhøj Larsen C; Smidt K; Jakobsen P; Hansen SH; Vind-Kezunovic D; Gluud LL; Grønhøj Larsen F
Br J Dermatol; 2014 Feb; 170(2):408-14. PubMed ID: 23909409
[TBL] [Abstract][Full Text] [Related]
3. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
4. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
[TBL] [Abstract][Full Text] [Related]
5. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Treatment with Oral Alitretinoin and Oral Cyclosporine for Chronic Hand Eczema: A Retrospective Review of 118 Cases.
Jang YJ; Yoon JH; Park EJ; Kim KJ; Kim KH
Acta Derm Venereol; 2020 Jan; 100(1):adv00043. PubMed ID: 31821516
[No Abstract] [Full Text] [Related]
7. Oral alitretinoin. Severe chronic hand eczema: this retinoid is too risky.
Prescrire Int; 2010 Apr; 19(106):62-3. PubMed ID: 20568484
[No Abstract] [Full Text] [Related]
8. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
10. Use of alitretinoin in moderate to severe chronic hand eczema: A real-world experience in Korea.
Kim HJ; Lee SK; Baek J; Roh JY
Dermatol Ther; 2019 Jul; 32(4):e12980. PubMed ID: 31168895
[No Abstract] [Full Text] [Related]
11. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
Gola M; Milanesi N; D'Erme AM
G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A.
Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Maares J; Schoetzau A; Meyer I
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():24-8. PubMed ID: 21443601
[TBL] [Abstract][Full Text] [Related]
13. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
14. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
15. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
16. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
Kumari V; Timm K; Kühl AA; Heine G; Worm M
Br J Dermatol; 2016 Dec; 175(6):1243-1250. PubMed ID: 27480504
[TBL] [Abstract][Full Text] [Related]
17. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
18. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
19. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
[TBL] [Abstract][Full Text] [Related]
20. Late onset of headache in a patient treated with alitretinoin.
Gurreri R; Pistone G; LA Vecchia M; Bongiorno MR
G Ital Dermatol Venereol; 2016 Apr; 151(2):209-10. PubMed ID: 26449913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
